RxDoctor Payments Data

Christopher Blankenship, APRN

Family · Beckley, WVNPI 1730774217

Payments from drug & device makers

$2,435in general payments, 2019–2025

Across 111 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$365
  • Pfizer$312
  • Johnson & Johnson$255
  • AbbVie$252
  • Bristol Myers Squibb$224
  • Daiichi Sankyo Inc.$146
  • plus $881 from 28 others

What the payments were for

  • Food & beverage$2,07285%
  • Education$36315%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,435 in reported general payments places this provider in the 80th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$47,291
Medicare patients
275
Services billed
2,673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban98$72,439
XareltoRivaroxaban27$28,087
Potassium Chloride45$1,000
Anastrozole88$970
Hydroxyurea26$890
Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12)58$404
Levothyroxine Sodium23$363
Ondansetron Hcl19$168
Prednisone14$135
Folic Acid34$90
Warfarin Sodium11$45

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$312$72,43998 claims
Johnson & JohnsonXarelto$255$28,08727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,507 family providers in West Virginia.

Other family in Beckley

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →